Catastrophic antiphospholipid syndrome presenting as fever of unknown origin
Antiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies with characteristic clinical manifestation, which include venous, arterial thrombosis, thrombotic microangiopathy, and recurrent fetal loss. The syndrome can be secondary to many causes including systemic lupus...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2012;volume=23;issue=1;spage=110;epage=113;aulast=Al-Beladi |
id |
doaj-3c94d3c965684ce6994ce8012dc5035c |
---|---|
record_format |
Article |
spelling |
doaj-3c94d3c965684ce6994ce8012dc5035c2020-11-24T23:44:04ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422012-01-0123111011310.4103/1319-2442.91313Catastrophic antiphospholipid syndrome presenting as fever of unknown originFatma I Al-BeladiAntiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies with characteristic clinical manifestation, which include venous, arterial thrombosis, thrombotic microangiopathy, and recurrent fetal loss. The syndrome can be secondary to many causes including systemic lupus erythematosus (SLE) or "primary" antiphospholipid syndrome (APLS). We report a case of a man with catastrophic antiphospholipid syndrome (CAPS), which occurs when three or more organ systems are affected by thrombosis in less than a week. Catastrophic antiphospholipid syndrome is uncommon but often fatal. The patient received a successful treatment that controlled this disease and included intravenous heparin, antiplatelet, intravenous corticosteroid, and plasmapheresis.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2012;volume=23;issue=1;spage=110;epage=113;aulast=Al-Beladi |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fatma I Al-Beladi |
spellingShingle |
Fatma I Al-Beladi Catastrophic antiphospholipid syndrome presenting as fever of unknown origin Saudi Journal of Kidney Diseases and Transplantation |
author_facet |
Fatma I Al-Beladi |
author_sort |
Fatma I Al-Beladi |
title |
Catastrophic antiphospholipid syndrome presenting as fever of unknown origin |
title_short |
Catastrophic antiphospholipid syndrome presenting as fever of unknown origin |
title_full |
Catastrophic antiphospholipid syndrome presenting as fever of unknown origin |
title_fullStr |
Catastrophic antiphospholipid syndrome presenting as fever of unknown origin |
title_full_unstemmed |
Catastrophic antiphospholipid syndrome presenting as fever of unknown origin |
title_sort |
catastrophic antiphospholipid syndrome presenting as fever of unknown origin |
publisher |
Wolters Kluwer Medknow Publications |
series |
Saudi Journal of Kidney Diseases and Transplantation |
issn |
1319-2442 |
publishDate |
2012-01-01 |
description |
Antiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies with characteristic clinical manifestation, which include venous, arterial thrombosis, thrombotic microangiopathy, and recurrent fetal loss. The syndrome can be secondary to many causes including systemic lupus erythematosus (SLE) or "primary" antiphospholipid syndrome (APLS). We report a case of a man with catastrophic antiphospholipid syndrome (CAPS), which occurs when three or more organ systems are affected by thrombosis in less than a week. Catastrophic antiphospholipid syndrome is uncommon but often fatal. The patient received a successful treatment that controlled this disease and included intravenous heparin, antiplatelet, intravenous corticosteroid, and plasmapheresis. |
url |
http://www.sjkdt.org/article.asp?issn=1319-2442;year=2012;volume=23;issue=1;spage=110;epage=113;aulast=Al-Beladi |
work_keys_str_mv |
AT fatmaialbeladi catastrophicantiphospholipidsyndromepresentingasfeverofunknownorigin |
_version_ |
1725500159721209856 |